Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.


BACKGROUND Non-small cell lung cancer is the most frequently cause of cancer-related death in the world. To explore the technical feasibility, we detected aberrant promoter methylation of P16 in exhaled breath condensate which was a new, non-invasive tool for diagnosis and screening program of NSCLC. METHODS We analyzed aberrant promoter methylation of… (More)
DOI: 10.1016/j.lungcan.2013.09.008